(Q34998096)

5 August 2017

1 reference

title

Intranasal corticosteroids for allergic rhinitis (English)

1 reference

5 August 2017

Amanda J Trangsrud

1

1 reference

5 August 2017

Amy L Whitaker

series ordinal

2

1 reference

5 August 2017

Ralph E Small

series ordinal

3

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

22

1 reference

5 August 2017

11

1 reference

5 August 2017

1458-1467

1 reference

Impact of allergic rhinitis treatment on quality of life

5 August 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Intranasal corticosteroids for allergic rhinitis: how do different agents compare?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Glucocorticosteroids and rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Pharmacotherapy of allergic rhinitis: corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Use of nasal steroids in managing allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Ideal pharmacotherapy for allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

A comparison of the anti-inflammatory properties of intranasal corticosteroids and antihistamines in allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

New insights into the mechanisms of immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Intranasal fluticasone propionate. A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Mode of action of intranasal corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

The rationale for use of topical corticosteroids in allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Triamcinolone acetonide. A review of its pharmacological properties and therapeutic efficacy in the management of allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Binding kinetics of fluticasone propionate to the human glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Development of fluticasone propionate and comparison with other inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Safety of inhaled and intranasal corticosteroids: lessons for the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Pharmacokinetics of intranasal corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Systemic activity versus systemic adverse effects of nasal glucocorticoids in the treatment of allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Systemic effects of two nasally administered glucocorticosteroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Pharmacologic management of allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Once-daily mometasone furoate nasal spray: efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

A placebo‐controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non‐allergic perennial rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Comparison of flunisolide and beclomethasone dipropionate in seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Triamcinolone acetonide aqueous nasal spray for the treatment of patients with perennial allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Triamcinolone acetonide Aqueous nasal spray in patients with seasonal ragweed allergic rhinitis: a placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

A randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

Clinical review of once-daily beclomethasone dipropionate for seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.16.1458.33692

10.1592/PHCO.22.16.1458.33692

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference